---
title: "HOME BP: supported self-monitoring in primary care — Vironix"
description: "Supported home monitoring produced a modest additional reduction in systolic pressure."
image: "https://www.vironix.ai/_astro/open_graph_vironix.uvCNQF08_27tYOt.webp"
canonical: "https://www.vironix.ai/research/studies/home-bp-trial"
source: "https://www.vironix.ai/research/studies/home-bp-trial"
---

<!-- Generated from https://www.vironix.ai/research/studies/home-bp-trial. Do not edit this file directly. -->

[Home](https://www.vironix.ai/index.md) [Research & Evidence](https://www.vironix.ai/research.md) HOME BP: supported self-monitoring in primary care

Study summary · 2021 · Randomized trial

# HOME BP: supported self-monitoring in primary care

Supported home monitoring produced a modest additional reduction in systolic pressure.

Summary by Vironix Health · Source review: November 11, 2026  
[How we select and interpret evidence](https://www.vironix.ai/research/methodology.md)

## Original publication

[Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial](https://www.bmj.com/content/372/bmj.m4858)

Richard J McManus; Paul Little; Beth Stuart; Katherine Morton; James Raftery; Jo Kelly; Katherine Bradbury; Jin Zhang; Shihua Zhu; Elizabeth Murray; Carl R May; Frances S Mair; Susan Michie; Peter Smith; Rebecca Band; Emma Ogburn; Julie Allen; Cathy Rice; Jacqui Nuttall; Bryan Williams; Lucy Yardley; HOME BP investigators

Universities of Oxford, Southampton, Bristol, Glasgow and University College London; London School of Hygiene and Tropical Medicine; UK primary-care practices

The BMJ · Online: January 19, 2021 · Issue: 2021

[DOI: 10.1136/bmj.m4858](https://doi.org/10.1136/bmj.m4858)[Published correction](https://pmc.ncbi.nlm.nih.gov/articles/PMC9607877/)[PubMed](https://pubmed.ncbi.nlm.nih.gov/33468518/)[Open-access source](https://pmc.ncbi.nlm.nih.gov/articles/PMC7814507/)

Journal article with 2022 correction, DOI 10.1136/bmj.m2216. · Full text consulted. This article has a linked published correction.

## What was studied

Design

Randomized trial

Population

Adults with treated but poorly controlled hypertension and internet access

Sample

622 participants

Intervention

Home BP, digital feedback and clinician-directed medication titration

Comparator

Usual primary care

Follow-up

12 months

Setting

United Kingdom; 76 general practices

## Methods

Unmasked randomized trial with automated primary-endpoint ascertainment.

## Findings

Adjusted systolic BP difference at one year was −3.4 mmHg (95% CI −6.1 to −0.8). Adverse effects were similar.

## Limitations

One-year BP measurements were available for 552 of 622 participants (88.6%); missing outcomes were imputed. Internet access was required, and the intervention bundled several components. A 2022 correction fixes baseline Table 1 counts.

## What this means for care delivery

Plan clinical treatment responses and assisted access alongside home measurements.

## Explore the evidence

[RPM](https://www.vironix.ai/research.md#careModels=rpm)[Hypertension](https://www.vironix.ai/research.md#conditions=hypertension)

## Guides citing this study

-   [How do RPM and CCM work together in a managed care team?](https://www.vironix.ai/research/guides/care-team-workflows.md)
-   [Does remote patient monitoring improve blood pressure control?](https://www.vironix.ai/research/guides/blood-pressure-control.md)

```json
{
  "@context": "https://schema.org",
  "@type": "Organization",
  "@id": "https://www.vironix.ai/#organization",
  "name": "Vironix Health",
  "alternateName": "Vironix",
  "url": "https://www.vironix.ai",
  "logo": "https://www.vironix.ai/_astro/Vironix_Logo_Primary_300.CFX8xheF.png",
  "description": "Vironix is a digital health platform that enables healthcare providers to provide AI-enabled virtual care services to their patients, including remote patient monitoring, chronic care management, remote therapeutic monitoring, and more.",
  "sameAs": [
    "https://www.linkedin.com/company/vironix-health"
  ]
}
{
  "@context": "https://schema.org",
  "@type": "WebSite",
  "@id": "https://www.vironix.ai/#website",
  "url": "https://www.vironix.ai",
  "name": "Vironix Health",
  "publisher": {
    "@id": "https://www.vironix.ai/#organization"
  },
  "inLanguage": "en-US"
}
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [
    {
      "@type": "ListItem",
      "position": 1,
      "name": "Home",
      "item": "https://www.vironix.ai/"
    },
    {
      "@type": "ListItem",
      "position": 2,
      "name": "Research & Evidence",
      "item": "https://www.vironix.ai/research"
    },
    {
      "@type": "ListItem",
      "position": 3,
      "name": "HOME BP: supported self-monitoring in primary care",
      "item": "https://www.vironix.ai/research/studies/home-bp-trial.html"
    }
  ]
}
{
  "@context": "https://schema.org",
  "@type": "Article",
  "@id": "https://www.vironix.ai/research/studies/home-bp-trial#article",
  "headline": "HOME BP: supported self-monitoring in primary care",
  "description": "Supported home monitoring produced a modest additional reduction in systolic pressure.",
  "url": "https://www.vironix.ai/research/studies/home-bp-trial",
  "mainEntityOfPage": "https://www.vironix.ai/research/studies/home-bp-trial",
  "inLanguage": "en-US",
  "articleSection": "Research & Evidence",
  "isPartOf": {
    "@id": "https://www.vironix.ai/research"
  },
  "datePublished": "2026-11-16T16:43:58.017Z",
  "dateModified": "2026-11-16T16:43:58.028Z",
  "author": {
    "@type": "Organization",
    "name": "Vironix Health",
    "@id": "https://www.vironix.ai/#organization",
    "url": "https://www.vironix.ai/about"
  },
  "publisher": {
    "@id": "https://www.vironix.ai/#organization"
  },
  "citation": {
    "@type": "ScholarlyArticle",
    "@id": "https://doi.org/10.1136/bmj.m4858",
    "name": "Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial",
    "author": [
      {
        "@type": "Person",
        "name": "Richard J McManus"
      },
      {
        "@type": "Person",
        "name": "Paul Little"
      },
      {
        "@type": "Person",
        "name": "Beth Stuart"
      },
      {
        "@type": "Person",
        "name": "Katherine Morton"
      },
      {
        "@type": "Person",
        "name": "James Raftery"
      },
      {
        "@type": "Person",
        "name": "Jo Kelly"
      },
      {
        "@type": "Person",
        "name": "Katherine Bradbury"
      },
      {
        "@type": "Person",
        "name": "Jin Zhang"
      },
      {
        "@type": "Person",
        "name": "Shihua Zhu"
      },
      {
        "@type": "Person",
        "name": "Elizabeth Murray"
      },
      {
        "@type": "Person",
        "name": "Carl R May"
      },
      {
        "@type": "Person",
        "name": "Frances S Mair"
      },
      {
        "@type": "Person",
        "name": "Susan Michie"
      },
      {
        "@type": "Person",
        "name": "Peter Smith"
      },
      {
        "@type": "Person",
        "name": "Rebecca Band"
      },
      {
        "@type": "Person",
        "name": "Emma Ogburn"
      },
      {
        "@type": "Person",
        "name": "Julie Allen"
      },
      {
        "@type": "Person",
        "name": "Cathy Rice"
      },
      {
        "@type": "Person",
        "name": "Jacqui Nuttall"
      },
      {
        "@type": "Person",
        "name": "Bryan Williams"
      },
      {
        "@type": "Person",
        "name": "Lucy Yardley"
      },
      {
        "@type": "Organization",
        "name": "HOME BP investigators"
      }
    ],
    "datePublished": "2021-01-19",
    "url": "https://www.bmj.com/content/372/bmj.m4858",
    "identifier": "10.1136/bmj.m4858",
    "isPartOf": {
      "@type": "Periodical",
      "name": "The BMJ"
    }
  }
}
```
